Graham Capital Management »

Relmada Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $124k 26k 4.83
2022-12-31 $92k 26k 3.49

More positions owned by Graham Capital Management

Strategy Cl A New (MSTR)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Applied Digital Corp Note 2.750% 6/0 (Principal)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Fidelity Wise Origin Bitcoin SHS Put Option (FBTC)
Sunrun Note 4.000% 3/0 (Principal)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Rivian Automotive Note 3.625%10/1 (Principal)
Green Plains Note 5.250%11/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
The Realreal Debt 4.000% 2/1 (Principal)
Groupon Note 4.875% 6/3 (Principal)
Amazon (AMZN)
Calumet Put Option (CLMT)
Eos Energy Enterprises Com Cl A (EOSE)

View all positions for Graham Capital Management

Top funds holding Relmada Therapeutics

Marshall Wace
Ikarian Capital
Braidwell
BlackRock
Vanguard Group
Opaleye Management
Geode Capital Management
Boothbay Fund Management
Driehaus Capital Management
CI Private Wealth
Acadian Asset Management
Susquehanna International
Diadema Partners
State Street Corporation
AdvisorShares Investments

View all funds holding Relmada Therapeutics